# Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera

> **NCT00241241** · PHASE2 · COMPLETED · sponsor: **PV-Nord** · enrollment: 40 (—)

## Conditions studied

- Polycythemia Vera

## Interventions

- **DRUG:** pegylated interferon-alfa 2a

## Key facts

- **NCT ID:** NCT00241241
- **Lead sponsor:** PV-Nord
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-10
- **Final completion:** 2008-01
- **Target enrollment:** 40 (—)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00241241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00241241, "Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00241241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*